Candida species are the 4th most common cause of nosocomial bloodstream infections in North America. It is not widely appreciated, however, that many of these infections are polymicrobial, that is, that bacteria and occasionally more than 1 species of Candida are present in the same blood culture bottle. Analysis of 2 groups of candidemic patients and a review of the literature were performed. Review of 141 candidemic patients from 8 Veterans Affairs hospitals and 231 patients from a tertiary care hospital with transplant services was performed. Of the 372 patients with candidemia, 100 (27%) had polymicrobial blood cultures: 88 patients (24%) had synchronous bacteremia and 12 patients (3%) had more than 1 species of Candida. One hundred bacteria were isolated from these patients, 69 were Gram positive, and 31 were Gram negative. Candidemia was shown to occur in a setting of polymicrobial bacteremia extending over days, whereas Staphylococcus aureus and coagulase-negative Staphylococcus were less frequently associated with polymicrobial bloodstream infections. Review of more than 8000 reported episodes of candidemia revealed high rates of polymicrobial infection occurring with candidemia. Of blood cultures isolating Candida, 23% were polymicrobial and 4% had more than 1 species of Candida. Thus, almost 1 in 4 patients with candidemia will have a polymicrobial bloodstream infection. As detection of bloodborne infections evolves toward nonculture methodologies, documentation of the frequency of polymicrobial bloodstream infections involving Candida is important. This finding may have treatment implications for clinicians.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2007.07.001DOI Listing

Publication Analysis

Top Keywords

polymicrobial bloodstream
16
bloodstream infections
16
species candida
12
polymicrobial
9
patients
9
infections involving
8
involving candida
8
candida species
8
patients review
8
review literature
8

Similar Publications

The risk factors and outcomes associated with persistent bacteremia are not well-defined. This retrospective cohort study analyzed 214 cases of bacteremia diagnosed between 2005 and 2022 at two university hospitals, focusing on the clinical and microbiologic characteristics and outcomes of persistent bacteremia. Persistent bacteremia, defined as the detection of for ≥5 days after the initial blood culture, occurred in 25.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the impact of the BioFire FilmArray Blood Culture Identification 2 panel on identifying pathogens and guiding antibiotic treatment in critically ill sepsis patients.
  • The research was a prospective observational study involving patients in the ICU with sepsis due to bloodstream infections, comparing results from the new panel to traditional blood cultures in terms of accuracy and speed.
  • Results showed high sensitivity and specificity for identifying pathogens, with the new panel providing results significantly faster, suggesting it could enhance treatment effectiveness and improve outcomes for these patients.
View Article and Find Full Text PDF

Background: Blood cultures are essential for diagnosing bloodstream infections, but current phenotypic tests for antimicrobial resistance (AMR) provide limited information. Oxford Nanopore Technologies introduces nanopore sequencing with adaptive sampling, capable of real-time host genome depletion, yet its application directly from blood cultures remains unexplored. This study aimed to identify pathogens and predict AMR using nanopore sequencing.

View Article and Find Full Text PDF

Background: Data on infections in children are scarce in the context of earthquakes. Here, we describe our clinical experiences regarding infections in pediatric victims after the earthquakes in Kahramanmaraş/Türkiye.

Methods: Trauma patients after the Kahramanmaraş earthquakes, aged under 18 years and admitted to our hospital, were evaluated retrospectively.

View Article and Find Full Text PDF
Article Synopsis
  • Rapid antimicrobial susceptibility testing (rAST) from blood cultures is crucial for selecting effective antibiotics for bloodstream infections, with the LifeScale system offering a promising new approach.
  • LifeScale utilizes microfluidic sensors and mechanical resonators to quickly analyze individual microbes and deliver reliable rAST results in under 5 hours, outpacing standard methods.
  • Notably, LifeScale addresses challenges with polymicrobial cultures and shows strong agreement with the current standard of care, potentially allowing for quicker clinical decision-making without the need for confirmatory tests.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!